EXHIBIT 31.2

CERTIFICATIONS
required by Rules 13a-14(a) or 15d-14(a)

I, Linden Boyne, certify that:

1. I have  reviewed  this  quarterly  report  on Form  10-QSB  of  Bioaccelerate
Holdings, Inc., the issuer;

2. Based on my knowledge, this report does not contain any untrue statement of a
material fact or omit to state a material fact  necessary to make the statements
made, in light of the  circumstances  under which such statements were made, not
misleading with respect to the period covered by this report;

3.  Based  on my  knowledge,  the  financial  statements,  and  other  financial
information included in this report, fairly present in all material respects the
financial  condition,  results of operations and cash flows of the issuer as of,
and for, the periods presented in this report;

4. The issuer's other certifying officers and I are responsible for establishing
and maintaining  disclosure  controls and procedures (as defined in Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the issuer and have:

a. Designed such disclosure  controls and procedures,  or caused such disclosure
controls and  procedures to be designed  under our  supervision,  to ensure that
material  information  relating  to  the  issuer,   including  its  consolidated
subsidiaries, is made known to us by others within those entities,  particularly
during the period in which this report is being prepared;

b. Designed  such  internal  control over  financial  reporting,  or caused such
internal control over financial  reporting to be designed under our supervision,
to provide reasonable assurance regarding the reliability of financial reporting
and the preparation of financial  statements for external purposes in accordance
with generally accepted accounting principles;

c.  Evaluated  the  effectiveness  of  the  issuer's   disclosure  controls  and
procedures and presented in this report our conclusions  about the effectiveness
of the disclosure  controls and procedures,  as of the end of the period covered
by this report based on such evaluation; and

d.  Disclosed  in this report any change in the issuer's  internal  control over
financial reporting that occurred during the issuer's most recent fiscal quarter
(the issuer's  fourth fiscal  quarter in the case of an annual  report) that has
materially affected,  or is reasonably likely to materially affect, the issuer's
internal control over financial reporting; and

5. The issuer's other  certifying  officers and I have  disclosed,  based on our
most recent evaluation,  to the issuer's auditors and the audit committee of the
issuer's board of directors (or persons performing the equivalent functions):

a. All  significant  deficiencies  and  material  weaknesses  in the  design  or
operation of internal  control over  financial  reporting  which are  reasonably
likely to adversely  affect the issuer's ability to record,  process,  summarize
and report financial information; and

b. Any  fraud,  whether  or not  material,  that  involves  management  or other
employees  who have a  significant  role in the issuer's  internal  control over
financial reporting.



<PAGE>


    Date: November 14, 2005    By: /s/ Linden Boyne
                                   ---------------------------------------------
                                   Linden Boyne, Secretary-Treasurer & Director
                                   (Chief Financial Officer)